S E Salmon|M Seligmann - JoVE Visualize

Showing results (241-250 of 283) with videos related to

Pageof 29

Sort By:

The New England Journal of Medicine|May 24, 1990

Relation of cytogenetic abnormalities and clinical outcome in metastatic melanomaJ M Trent, F L Meyskens, S E Salmon, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998

Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group StudyS E Salmon, J J Crowley, S P Balcerzak, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1981

Chemotherapy of ovarian cancer directed by the human tumor stem cell assayD S Alberts, H S Chen, S E Salmon, et al.

Investigational New Drugs|January 1, 1986

Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanomaT A Braich, S E Salmon, A Robertone, et al.

Nature|March 26, 1981

Diversity of immunoglobulin expression in leukaemic cells resembling B-lymphocyte precursorsL B Vogler, J L Preud'homme, M Seligmann, et al.

Cancer|August 15, 1984

Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factorsH Castro-Malaspina, G Schaison, S Passe, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1981

Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapyT E Moon, S E Salmon, C S White, et al.

Investigational New Drugs|May 1, 1990

Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group studyE H Kraut, J J Crowley, M R Grever, et al.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982

Adjuvant treatment of node-positive breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: interim results of an ongoing clinical trialS E Jones, S E Salmon, H Allen, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1997

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancersD S Alberts, P T Fanta, K L Running, et al.

Pageof 29

Showing results (241-250 of 283) with videos related to

Sort By:

Pageof 29

The New England Journal of Medicine|May 24, 1990

Relation of cytogenetic abnormalities and clinical outcome in metastatic melanomaJ M Trent, F L Meyskens, S E Salmon, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998

Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group StudyS E Salmon, J J Crowley, S P Balcerzak, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1981

Chemotherapy of ovarian cancer directed by the human tumor stem cell assayD S Alberts, H S Chen, S E Salmon, et al.

Investigational New Drugs|January 1, 1986

Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanomaT A Braich, S E Salmon, A Robertone, et al.

Nature|March 26, 1981

Diversity of immunoglobulin expression in leukaemic cells resembling B-lymphocyte precursorsL B Vogler, J L Preud'homme, M Seligmann, et al.

Cancer|August 15, 1984

Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factorsH Castro-Malaspina, G Schaison, S Passe, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1981

Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapyT E Moon, S E Salmon, C S White, et al.

Investigational New Drugs|May 1, 1990

Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group studyE H Kraut, J J Crowley, M R Grever, et al.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982

Adjuvant treatment of node-positive breast cancer with adriamycin-cyclophosphamide with or without radiation therapy: interim results of an ongoing clinical trialS E Jones, S E Salmon, H Allen, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1997

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancersD S Alberts, P T Fanta, K L Running, et al.

Pageof 29